Alterations in Gait, Strength, and Power After Ruck Marching

Fatigue Clinical Trial

— SPARTAN  

Official title:

Alterations in Gait, Strength, and Power After Ruck Marching

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05309603
• Other study ID #: STUDY00006175
• Status: Completed
• Phase: N/A
• Start date: March 21, 2022
• Est. completion date: July 21, 2023

Study information

• Verified date: August 2023
• Source: State University of New York at Buffalo
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to determine change in injury risk and performance variables in males and females after walking unloaded and carrying a load with two different distributions (high-pack placement and mid-pack placement) to identify differences in injury risk

Recruitment information / eligibility

• Status: Completed
• Enrollment: 26
• Est. completion date: July 21, 2023
• Est. primary completion date: July 21, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 39 Years

Eligibility

Inclusion Criteria:

• Healthy, physically active individuals

• 18-39 years old

Exclusion Criteria:

• History of musculoskeletal injury within the last six months or still under a physicians care for an injury occurring more than six month prior

• History of spinal disc injury

• History of cardiovascular, metabolic, respiratory, neural, or renal disease

• No previous history or education of completing resistance exercise

• Hypertensive or tachycardic during the screening visit (SBP > 139 mmHg, DBP > 89 mmHg, heart rate > 100 bpm)

• Taking medication or supplements with a known side effect of affecting physiologic responses to exercise (e.g., beta blockers, omega-3 fatty acids, statins, aspirin)

• Any form of tobacco or nicotine use

• A positive pregnancy test at any point in the study

• Study physician discretion based on any other medical condition or medication

• Gastrointestinal disease or previous surgery prohibiting internal body temperature pill use. Subjects who have any contraindication to internal body temperature pill ingestion will be given the option to insert the pill rectally (as a suppository) or use a rectal probe.

Related Conditions & MeSH terms

• Exercise
• Fatigue

Intervention

Other:
• Loaded Walking High
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried high on the back
• Loaded Walking Mid
Walking three miles on a treadmill at a self-selected speed while wearing a backpack with weight carried on the mid-back
• Walking
Walking three miles on a treadmill at a self-selected speed

Locations

Country	Name	City	State
United States	University at Buffalo	Buffalo	New York

Sponsors (1)

Lead Sponsor	Collaborator
State University of New York at Buffalo

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Oxygen Consumption	Oxygen consumption will be measured using indirect calorimetry	Upon completion of 3 miles of walking, an average of 45 minutes
Primary	Increased muscular jerk	Jerk will be measured using accelerometers placed at the torso and ankle	Upon completion of 3 miles of walking, an average of 45 minutes